Delivery Order SPE2DB22D1103-SPE2DB25F1638
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,634.88 to AmerisourceBergen Drug Corp for the supply of Eletriptan HBr 20 mg tablets in unit dose packages of six on September 2, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, issued competitively under open procurement requirements. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, with an ultimate completion date of September 3, 2025....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,815.17 on August 27, 2025, for the supply of Eletriptan HBr 40 mg tablets in unit dose packages of six. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 28, 2025. Eletriptan is a triptan-class medication used to treat acute migraine headaches, representing part of the agency's pharmaceutical procurement...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,568,508,331 units of the medication eletriptan hydrobromide 40 mg tablets. The contract has a ceiling value of $1,242.28 and a period of performance through June 11, 2025. It is a firm-fixed price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eletriptan HBR 20 mg tablets, a prescription medication, with a ceiling value of $3,001.04 and a performance period ending on July 8, 2025. The contract is not set aside and was awarded on a firm-fixed price basis. Amerisourcebergen Drug Corp, the prime contractor, is a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,012.19 and is a delivery order for the supply of 4564713961 ELETRIPTAN HBR 40 MG TABLET UD 6S. The contract is not designated as a set-aside and has an ultimate completion date of May 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract award is for the delivery of Eletriptan HBR 20 mg tablets, with a total ceiling value of $1,806.16 and a performance period through March 7, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,181.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4559037029 - Eletriptan HBR 40 MG Tablet UD 6S, with a completion date of November 9, 2022. It is a Firm Fixed Price contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,058.10 firm fixed-price contract is for the supply of ELETRIPTAN HBR 40 MG TABLET UD 6S. The contract has a period of performance through June 12, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization...
- This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,780.83 firm fixed-price delivery order is for the supply of Eletriptan HBR 40 MG Tablet UD 6S, a prescription migraine medication. The award has an ultimate completion date of August 8, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $1,273.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the provision of ELETRIPTAN HBR 40 MG TABLET UD 6S, a prescription medication. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also does business as Amerisourcebergen. The contract does not have a set-aside designation, indicating it was awarded through...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25F1638Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Eletriptan HBr 40 mg tablets in unit dose packaging (6-count). This competitively awarded, non-set-aside contract carries a ceiling value of $4,173.59 and has a firm fixed price structure, with an ultimate completion date of August 11, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. The current delivery order for Eletriptan, a common migraine treatment, exemplifies the routine pharmaceutical procurement DLA executes through this contract to support Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/8/25 |